113 reports of this reaction
12.6% of all ISOPROTERENOL HYDROCHLORIDE reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for ISOPROTERENOL HYDROCHLORIDE, manufactured by Cipla USA Inc.. There are 113 FDA adverse event reports linking ISOPROTERENOL HYDROCHLORIDE to DRUG INEFFECTIVE. This represents approximately 12.6% of all 894 adverse event reports for this drug.
Patients taking ISOPROTERENOL HYDROCHLORIDE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is a frequently reported adverse event for ISOPROTERENOL HYDROCHLORIDE, accounting for a significant proportion of all reports.
In addition to drug ineffective, the following adverse reactions have been reported for ISOPROTERENOL HYDROCHLORIDE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 113 FDA reports for ISOPROTERENOL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 12.6% of all adverse event reports for ISOPROTERENOL HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking ISOPROTERENOL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.